ClassID:

21476

A61K49/06 - CPC Classification

Classification description:

Preparations for testing Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Sub-classes:
Recent Application in this class:
#1
20250387322
2025-12-25

DRUG DELIVERY AGENTS FOR PREVENTION OR TREATMENT OF PULMONARY DISEASE

#2
20250321305
2025-10-16

System and Methods for Organ-Targeted Multinuclear Functional and Molecular Magnetic Resonance Imaging

#3
20250295817
2025-09-25

MRI COMPOSITION AND ITS USE IN NONFASTING SUBJECTS

#4
20250295691
2025-09-25

Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking

#5
20250011287
2025-01-09

FLUORINE-CONTAINING COMPOUND AND CONTRAST AGENT

#6
20240366800
2024-11-07

PURIFIED SIGNAL-ENHANCED CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING

#7
20240299593
2024-09-12

SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS

#8
20240190897
2024-06-13

NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS

#9
20240066152
2024-02-29

CONTRAST AGENT FOR DETECTING CARTILAGE DAMAGE AND METHOD AND PROGRAM FOR EXAMINING CARTILAGE DAMAGE USING SAID CONTRAST AGENT

#10
20230381434
2023-11-30

Compositions and devices to administer pharmaceutical compositions nasally

#11
20230358732
2023-11-09

METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES

#12
20230044475
2023-02-09

COMPOSITIONS AND METHODS INVOLVING AMINO ACIDS FOR THE TREATMENT OF FAT INFILTRATIONS IN MUSCLE

#13
20230022136
2023-01-26

DIFFUSIVITY CONTRAST AGENTS FOR MEDICAL IMAGING

#14
20230014738
2023-01-19

Novel Compositions that Mimic Adipose Tissue in MRI

#15
20220357322
2022-11-10

Methods and materials for identifying and treating autoimmune GFAP astrocytopathy

#16
20220110524
2022-04-14

QUANTITATIVE MEASUREMENT OF THE PERIVASCULAR SPACE FOR CNS AND BRAIN DISORDERS

#17
20220031827
2022-02-03

Tetanus toxoid and CCL3 improve DC vaccines

#18
20220009854
2022-01-13

A SERIES OF CATALYSTS FOR THE HYPERPOLARISATION OF SUBSTRATES

#19
20210363161
2021-11-25

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#20
20210353780
2021-11-18

Ascorbate formulations and methods of use as contrast agents

#21
20210290780
2021-09-23

Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices

#22
20210213033
2021-07-15

Estrogen therapy for brain gray matter atrophy and associated disability

#23
20210088606
2021-03-25

MAGNETIC APPARATUS

#24
20200386837
2020-12-10

Hybrid multiferroic nanoparticles as MRI contrast agent for sensing of electric fields in a human body

#25
20200376143
2020-12-03

Methods for preserving a subject and using imaging contrast agents

#26
20200359969
2020-11-19

METHOD FOR INTEGRATING LARGE SCALE BIOLOGICAL DATA WITH IMAGING

#27
20200330617
2020-10-22

Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound

#28
20200323943
2020-10-15

MALIGNANT TUMOR TARGET PEPTIDE

#29
20200315468
2020-10-08

Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage

#30
20200315456
2020-10-08

Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage

#31
20200297873
2020-09-24

Contrast agents for magnetic resonance imaging

#32
20200171175
2020-06-04

Multipurpose medical image indicator and method for manufacturing the same

#33
20200115391
2020-04-16

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#34
20200046919
2020-02-13

COMPOSITIONS AND DEVICES TO ADMINISTER PHARMACEUTICAL COMPOSITIONS NASALLY

#35
20200046858
2020-02-13

Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices

#36
20190376965
2019-12-12

Methods and materials for identifying and treating autoimmune GFAP astrocytopathy

#37
20190374659
2019-12-12

SYSTEM AND METHOD FOR IMAGING MACROPHAGE ACTIVITY USING DELTA RELAXATION ENHANCED MAGNETIC RESONANCE IMAGING

#38
20190336231
2019-11-07

Determination of structure and traversal of occlusions using magnetic particles

#39
20190298863
2019-10-03

Process for the preparation of hyperpolarized carboxylate compounds

#40
20190254528
2019-08-22

Pharmaceutical Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes

#41
20190247520
2019-08-15

NON-INVASIVE DETECTION OF DISEASE PROGRESSION AND THERAPEUTIC EFFICACY FOR MUSCULAR DYSTROPHIES AND DISEASES

#42
20190231907
2019-08-01

Metal complexes with bisphophonate or pyrophosphate useful as imaging agents

#43
20190231906
2019-08-01

NANOPARTICLE DIAGNOSTIC AND METHODS FOR TREATING DISEASE

#44
20190225625
2019-07-25

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#45
20190225491
2019-07-25

Method of purifying metal oxide particles and uses thereof

#46
20190216954
2019-07-18

Ascorbate formulations and methods of use as contrast agents

#47
20190175684
2019-06-13

Malignant tumor target peptide

#48
20190111160
2019-04-18

Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents

#49
20190054194
2019-02-21

System and Method For Evaluation of Subjects Using Magnetic Resonance Imaging and Oxygen-17

#50
20190041483
2019-02-07

Calibration of MRI systems using pre-defined concentrations of F isotopes as reference

#51
20190002575
2019-01-03

METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS

#52
20180369427
2018-12-27

Non-nutritive sweeteners and polyols as imaging agents

#53
20180360999
2018-12-20

Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices

#54
20180333506
2018-11-22

Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury

#55
20180292479
2018-10-11

Magnetic apparatus

#56
20180292478
2018-10-11

MAGNETIC APPARATUS

#57
20180275240
2018-09-27

Imaging phantom and systems and methods of using same

#58
20180253844
2018-09-06

Method and image processor for evaluating a contrast agent-enhanced magnetic resonance slice image of a heart

#59
20180237532
2018-08-23

METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS

#60
20180236054
2018-08-23

Tetanus toxoid and CCL3 improve DC vaccines

#61
20180230182
2018-08-16

HYPERPOLARIZATION OF AMINO ACID RESIDUES FOR PRODUCING HYPERPOLARIZED PEPTIDES

#62
20180071410
2018-03-15

Contrast agents for magnetic resonance imaging

#63
20180025489
2018-01-25

Quantifying mass effect deformation with structural radiomics in brain tumor patients

#64
20170348439
2017-12-07

In vivo detection of a xenon-binding cage molecule

#65
20170326258
2017-11-16

CONTRAST AGENTS BASED ON LONG-LIVED NUCLEAR SINGLET STATES AND RELATED METHODS

#66
20170312309
2017-11-02

INTRADIALYTIC ADMINISTRATION OF SODIUM THIOSULFATE

#67
20170309025
2017-10-26

In vivo detection of EGFR mutation in glioblastoma via MRI signature consistent with deep peritumoral infiltration

#68
20170290845
2017-10-12

Estrogen therapy for brain gray matter atrophy and associated disability

#69
20170267699
2017-09-21

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#70
20170267698
2017-09-21

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#71
20170258943
2017-09-14

Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging

#72
20170189564
2017-07-06

SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS

#73
20170189561
2017-07-06

Ascorbate formulations and methods of use as contrast agents

#74
20170189559
2017-07-06

Contrast agents for magnetic resonance imaging

#75
20170127948
2017-05-11

Pharmaceutical compositions of near IR closed chain, sulfo-cyanine dyes

#76
20170119909
2017-05-04

Room temperature ferromagnetic gadolinium silicide nanoparticles

#77
20170112947
2017-04-27

COMPOSITION FOR USE IN IMAGING

#78
20170100493
2017-04-13

RECEPTOR IMAGING SYSTEMS AND RELATED METHODS

#79
20170056532
2017-03-02

Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices

#80
20170035917
2017-02-09

METHODS OF TREATMENT OF CANCER

#81
20170028086
2017-02-02

Multipurpose medical image indicator and method for manufacturing the same

#82
20160354495
2016-12-08

Multicore Magnetic Particles

#83
20160345855
2016-12-01

METHODS OF TREATING BRAIN DISORDERS OR IDENTIFYING BIOMARKERS RELATED THERETO

#84
20160271240
2016-09-22

Tetanus toxoid and CCL3 improve DC vaccines

#85
20160243265
2016-08-25

Method for preparing a pharmaceutical formulation of lanthanide chelate in powder form

#86
20160193363
2016-07-07

Imaging brown adipose tissue with curcumin derivatives

#87
20160183815
2016-06-30

Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage

#88
20160166715
2016-06-16

Nanoparticle Diagnostic and Methods for Treating Disease

#89
20160136306
2016-05-19

SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS

#90
20160136305
2016-05-19

Cobalt-based MRI contrast agent and imaging system

#91
20160129138
2016-05-12

Octapod iron oxide nanoparticles as high performance Tcontrast agents for magnetic resonance imaging

#92
20160115130
2016-04-28

Alkoxyamines for the treatment of cancers

#93
20160061919
2016-03-03

IMAGING OF CREATINE KINASE ENZYME EXPRESSION IN CANCEROUS TISSUES

#94
20160045623
2016-02-18

Systems and Methods to Image Intercellular and Intercompartmental Defects with Magnetic Resonance Imaging (MRI)

#95
20160008496
2016-01-14

Imaging diagnostics by combining contrast agents

#96
20160000945
2016-01-07

Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon

#97
20150337044
2015-11-26

Methods for the Treatment of Multiple Sclerosis

#98
20150336997
2015-11-26

Manganese-based magnetic resonance contrast agents

#99
20150336996
2015-11-26

MANGANESE-BASED MAGNETIC RESONANCE CONTRAST AGENTS

#100
20150297717
2015-10-22

Pharmaceutical formulations

#101
20150224213
2015-08-13

TREATMENT OF NEUROLOGICAL DISORDERS

#102
20150217262
2015-08-06

Devices and methods for parahydrogen induced polarization

#103
20150217003
2015-08-06

Superparamagnetic nanoparticles as a contrast agent for magnetic resonance imaging (MRI) of magnetic susceptibility (T2*)

#104
20150182641
2015-07-02

Nanoparticulate contrast agent

#105
20150173847
2015-06-25

IMAGING MARKER AND UTILIZATION THEREOF

#106
20150166625
2015-06-18

Exendin-4 Peptide Analogues

#107
20150139909
2015-05-21

Compositions and methods for treating or preventing osteoarthritis

#108
20150086485
2015-03-26

Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging

#109
20150064113
2015-03-05

Contrast agents based on long-lived nuclear singlet states and related methods

#110
20150017102
2015-01-15

Cobalt-based MRI contrast agent and imaging system

#111
20150010477
2015-01-08

Method for the Treatment of Multiple Sclerosis

#112
20150004103
2015-01-01

Tumorspecific PET/MR(T1), PET/MR(T2) and PET/CT contrast agent

#113
20140377177
2014-12-25

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#114
20140332693
2014-11-13

METHOD OF USING THE NOVEL POLYMER GEL FOR MAGNETIC RESONANCE IMAGING (MRI) VALIDATION

#115
20140316246
2014-10-23

CHEMICAL EXCHANGE SATURATION TRANSFER ANGIOGRAPHY

#116
20140308213
2014-10-16

Color tunable multifunctional nanophosphor, synthesis method thereof, and polymer composite including the nanophosphor

#117
20140296702
2014-10-02

Magnetic resonance imaging (MRI) with self-navigation and self-registration

#118
20140296700
2014-10-02

Magnetic resonance imaging (MRI) based quantitative liver perfusion analysis

#119
20140294734
2014-10-02

Magnetic resonance imaging (MRI) based quantitative kidney perfusion analysis

#120
20140292330
2014-10-02

Quantifying magnetic resonance parameters

#121
20140292328
2014-10-02

Magnetic resonance imaging (MRI) with dual agent characterization

#122
20140292327
2014-10-02

Magnetic resonance imaging with switched-mode current-source amplifier having gallium nitride field effect transistors for parallel transmission in MRI

#123
20140292324
2014-10-02

Fiber optic telemetry for switched-mode current-source amplifier in magnetic resonance imaging (MRI)

#124
20140205541
2014-07-24

Method for Detection of Characteristics of Organ Fibrosis

#125
20140180206
2014-06-26

Opacity technology

#126
20140134102
2014-05-15

Fucoidans as ligands for the diagnosis of degenerative pathologies

#127
20140127126
2014-05-08

Compositions and methods for assessing and treating adrenal diseases and disorders

#128
20140113008
2014-04-24

Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage

#129
20140112870
2014-04-24

Systems and methods of performing NMR spectroscopy and MRI

#130
20140081009
2014-03-20

Contrast agents

#131
20140017168
2014-01-16

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#132
20130344000
2013-12-26

Treatment of cognitive impairment in a subject with a neurological autoimmune disease

#133
20130317354
2013-11-28

Opacity technology

#134
20130315821
2013-11-28

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#135
20130289385
2013-10-31

DEEP BRAIN STIMULATION OF MEMORY CIRCUITS IN ALZHEIMER'S DISEASE

#136
20130267828
2013-10-10

Method and apparatus for noninvasive quantitative detection of fibrosis in normal and viable myocardium by MRI

#137
20130243699
2013-09-19

Biodegradable Magnetic Nanoparticles and Related Methods

#138
20130230455
2013-09-05

USE OF GELSOLIN TO TREAT MULTIPLE SCLEROSIS AND TO DIAGNOSE NEUROLOGIC DISEASES

#139
20130230454
2013-09-05

Therapeutic angiogenesis for treatment of the spine and other tissues

#140
20130224113
2013-08-29

Imaging diagnostics by combining contrast agents

#141
20130209369
2013-08-15

Nanoparticles based on gadolinium coordination polymers as highly sensitive T1 MRI contrast agents

#142
20130142724
2013-06-06

Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging

#143
20130089505
2013-04-11

SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE

#144
20130084246
2013-04-04

Method and system for quantitative renal assessment

#145
20130078189
2013-03-28

Formation and uses of europium complexes

#146
20130039853
2013-02-14

Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

#147
20130017152
2013-01-17

METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS

#148
20120220472
2012-08-30

METHOD FOR INTEGRATING LARGE SCALE BIOLOGICAL DATA WITH IMAGING

#149
20120189551
2012-07-26

MRI markers, delivery and extraction systems, and methods of manufacture and use thereof

#150
20120183475
2012-07-19

Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies

#151
20120134920
2012-05-31

Methods and compositions for improved F labeling of proteins, peptides and other molecules

#152
20120123247
2012-05-17

Systems and methods for measuring and modeling in vivo manganese ion transport in a subject

#153
20120116360
2012-05-10

Treatment of neurological disorders

#154
20120093734
2012-04-19

PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMA

#155
20120087867
2012-04-12

Method for the Generation of Nuclear Hyper-Antipolarization in Solids Without the Use of High Magnetic Fields or Magnetic Resonant Excitation

#156
20120082624
2012-04-05

Method for preparing a pharmaceutical formulation of lanthanide chelate in powder form

#157
20120046538
2012-02-23

Method for estimating the physiological parameters defining the edema induced upon infusion of fluid from an intraparenchymally placed catheter

#158
20120010503
2012-01-12

Opacity technology

#159
20110293517
2011-12-01

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#160
20110274618
2011-11-10

DIAGNOSTIC AND/OR THERAPEUTIC AGENT, METHOD FOR THE MANUFACTURE THEREOF AND USE THEREOF

#161
20110243847
2011-10-06

IMAGING DIAGNOSTICS BY COMBINING CONTRAST AGENTS

#162
20110229414
2011-09-22

Contrast Agents For Detecting Protease Activity By Means Of Hyperpolarization And For Stratifying Patients

#163
20110152249
2011-06-23

EVALUATING CENTRAL NERVOUS SYSTEM

#164
20110124947
2011-05-26

METHOD FOR INTEGRATING LARGE SCALE BIOLOGICAL DATA WITH IMAGING

#165
20110104067
2011-05-05

METHODS FOR IN VIVO EVALUATION OF PULMONARY PHYSIOLOGY AND/OR FUNCTION USING NMR SIGNALS OF POLARIZED 129XE

#166
20110054175
2011-03-03

SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS

#167
20110050228
2011-03-03

AGENT FOR TRANSPORTING NUCLEAR SPIN ORDER AND FOR MAGNETIC RESONANCE IMAGING

#168
20110009605
2011-01-13

Contrast agents

#169
20110002853
2011-01-06

Use of the spin crossover complex [m(L)H]AN)as a magnetic resonance imaging contrast agent

#170
20100226903
2010-09-09

Method of delivering cell therapy to a target site

#171
20100219826
2010-09-02

Hyperpolaritzation of compounds for NMR, in particular by means of PHIP

#172
20100217110
2010-08-26

Magnetic resonance method and apparatus for automated analysis of joint inflammation, joint proteoglycan proportion, and joint osteoarthritis

#173
20100215581
2010-08-26

CONTRAST AGENTS FOR DETECTING PROSTATE CANCER

#174
20100129292
2010-05-27

METHOD AND APPARATUS FOR NONINVASIVE QUANTITATIVE DETECTION OF FIBROSIS IN THE HEART

#175
20100075925
2010-03-25

Hyperthermic technologies and therapeutic uses thereof

#176
20100062478
2010-03-11

DRUG FOR ANALYSIS OF WATER TRANSPORT FUNCTION OF MEMBRANE PROTEIN IN BIOLOGICAL TISSUE

#177
20100021428
2010-01-28

Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)

#178
20090304600
2009-12-10

Intradialytic administration of sodium thiosulfate

#179
20090297441
2009-12-03

Imaging Agents

#180
20090287077
2009-11-19

SYSTEM FOR DETECTING FUNCTION OF INTESTINAL BARRIER AND METHOD FOR USING THE SAME

#181
20090257976
2009-10-15

SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE

#182
20090246145
2009-10-01

Imaging Correlates of Neurogenesis With MRI

#183
20090246144
2009-10-01

System and method for indirectly measuring calcium ion efflux

#184
20090220431
2009-09-03

MAGNETIC RESONANCE IMAGING CONTRAST AGENTS CONTAINING WATER-SOLUBLE NANOPARTICLES OF MANGANESE OXIDE OR MANGANESE METAL OXIDE

#185
20090214433
2009-08-27

Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging

#186
20090214432
2009-08-27

Radicals and their use as paramagnetic agents in a DNP process

#187
20090196830
2009-08-06

Elimination of contrast agent concentration dependency in MRI

#188
20090175823
2009-07-09

Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

#189
20090162287
2009-06-25

Method of cardiac imaging

#190
20090155184
2009-06-18

Method of magnetic resonance imaging of the heart with paramagnetic MN

#191
20080292551
2008-11-27

Method to produce hyperpolarised carboxylates

#192
20080292160
2008-11-27

METHOD FOR ESTIMATING THE PHYSIOLOGICAL PARAMETERS DEFINING THE EDEMA INDUCED UPON INFUSION OF FLUID FROM AN INTRAPARENCHYMALLY PLACED CATHETER

#193
20080284429
2008-11-20

Situ Hyperpolarization of Imaging Agents

#194
20080208038
2008-08-28

Method and Device For Representing the Microstructure of the Lungs

#195
20080167549
2008-07-10

Method for enhancing contrast produced by MRI

#196
20080138440
2008-06-12

Methods of diagnosing and alleviating gadolinium toxicity

#197
20080113956
2008-05-15

Substituted Porphyrins

#198
20080107598
2008-05-08

Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

#199
20080081021
2008-04-03

Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation

#200
20080038275
2008-02-14

Method for the treatment of multiple sclerosis

#201
20080019919
2008-01-24

Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium

#202
20070286808
2007-12-13

METHOD FOR DISPLAY PRESENTATION OF LYMPH NODES

#203
20070196277
2007-08-23

Compositions and Methods for the Direct Therapy of Tumors

#204
20070179124
2007-08-02

Substituted Porphyrins

#205
20070128114
2007-06-07

Method for monitoring protein translation

#206
20070110669
2007-05-17

Methods for in vivo evaluation of pulmonary physiology and/or function using NMR signals of polarized Xe

#207
20070104644
2007-05-10

Inhibitor imaging agents

#208
20060269476
2006-11-30

Method for integrating large scale biological data with imaging

#209
20060177378
2006-08-10

Method for monitoring early treatment response

#210
20060177377
2006-08-10

Method for monitoring early treatment response

#211
20060173283
2006-08-03

Method of magnetic resonance imaging

#212
20060093554
2006-05-04

Galenical formulations

#213
20060078503
2006-04-13

1,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them

#214
20060074062
2006-04-06

Substituted porphyrins

#215
20060062731
2006-03-23

Dual gradient echo pulse sequence using interleaved spiral-out spiral-in k-space trajectories

#216
20060039856
2006-02-23

Magnetic resonance with stimulation

#217
20060034765
2006-02-16

MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation

#218
20060008416
2006-01-12

High resolution metabolic brain imaging

#219
20050276750
2005-12-15

Agents for imaging and diagnostic methods using them

#220
20050249704
2005-11-10

Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist

#221
20050207981
2005-09-22

Compositions and methods for determining substrate specificity of hydrolytic enzymes

#222
20050118105
2005-06-02

Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them

#223
20050090689
2005-04-28

Aminocarboxylate ligands having substituted aromatic amide moieties

#224
20050090653
2005-04-28

Metal complex compounds

#225
20050059881
2005-03-17

Method for determining in vivo concentration of a metabolite

#226
20050058598
2005-03-17

Method and apparatus for quantitatively evaluating a kidney

#227
20050020665
2005-01-27

Pharmaceutical composition for treating multiple sclerosis

#228
17884185
2023-05-23

Unassisted robotic surgery employing paramagnetic halo metallofullerenes as minimally invasive, precision scalpels or micronization particles through magnetic field manipulation and targeted exenteration patterned by programmed 3D imaging using needle or magnetic energy access and microelectronic semiconducting in non-stationary wafer-less space